CHEYENNE GASAWAY: Open Payments
NPI 1881133106 · WILMINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 36 payments from 12 companies in 2025. Trend: 2023 $722 · 2024 $795 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 8 | $157 |
| Lilly USA, LLC | 5 | $89 |
| Tandem Diabetes Care, Inc. | 4 | $63 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| BETA BIONICS, INC. | 3 | $50 |
| ABBVIE INC. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $28 |
| Corcept Therapeutics | 1 | $22 |
Products named: Dexcom G6 Transmitter, MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, Kerendia, iLet Bionic Pancreas, VRAYLAR, JARDIANCE, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
